COSA members formed the cancer survivorship group in November 2012 in recognition of the growing importance of survivorship care of people diagnosed with cancer. Our multidisciplinary Group provides a platform for the discussion and ongoing development of survivorship care in Australia. We recognise that quality survivorship care is essential to supporting the well-being of people diagnosed with cancer and their families.
The overarching aim of the COSA Survivorship Group is to advance care and research to improve outcomes for all Australians after cancer treatment.
Survivorship Group objectives include:
- Represent the needs of the broad range of health professionals involved in delivering care for cancer survivors
- Provide a forum for education, discussion and exchange of information between health professionals involved in cancer survivorship care
- Foster research in cancer survivorship
- Promote and advocate for improved survivorship services and access to care for all Australians living with and beyond cancer
- Engage stakeholders in the area of cancer survivorship care to ensure a coordinated, national approach to survivorship care in Australia and to facilitate policy development to inform such care
COSA Survivorship Group Strategic Plan
The Survivorship Group Strategic Plan set directions for 2019-2021 and our achievements are summarised here. The strategic plan identifies a range of priorities to help us work towards our objective of advancing care and research to improve outcomes for all Australians after cancer treatment. A new plan will be developed following consultation with the Group membership during late 2021. We are keen to hear from any members whose interests and expertise align with these activities and who would like to get involved. Please get in touch at cosa@cancer.org.au
Executive Committee
 |
|
| Chair: | Prof Michael Jefford (Peter MacCallum Cancer Centre, VIC) |
| Deputy Chair: | Prof Ray Chan (Caring Futures Institute, Flinders University SA) |
| Members: | Prof Gail Garvey (Menzies School of Health Research, QLD) |
| Dr Nicolas Hart (Queensland University of Technology / Princess Alexandra Hospital QLD; Edith Cowan University / University of Notre Dame Australia WA) | |
| Dr Mahesh Iddawela (Alfred Health / Latrobe Regional Hospital, VIC) | |
| Ms Rebecca McIntosh (healthAbility / Peter MacCallum Cancer Centre, VIC) | |
| Dr Elysia Thornton-Benko (General Practice, NSW / University of New South Wales) | |
| Dr Thomas Walwyn (Perth Children's Hospital, WA) | |
| Co-opted roles |
PRO Working Group Chair: Prof Bogda Koczwara (Flinders Centre for Innovation in Cancer, SA) |
Survivorship Group Terms of Reference - Council approved 6 August 2021
Survivorship Twitter - Follow and tag @COSA_Surviv
Community Guidelines
AGM Minutes
7 December 2020
